A patent landscape analysis of 22 common genetic diagnostic tests shows substantially fewer claims on genes per se than initially suggested but raises questions of legal uncertainty as to the claims' scope.
- Isabelle Huys
- Nele Berthels
- Geertrui Van Overwalle
